Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

89.95
-0.8300-0.91%
Post-market: 89.950.00000.00%16:15 EDT
Volume:3.06M
Turnover:276.18M
Market Cap:51.86B
PE:52.32
High:91.48
Open:90.78
Low:89.79
Close:90.78
52wk High:96.29
52wk Low:72.30
Shares:576.54M
Float Shares:575.03M
Volume Ratio:1.15
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.72
EPS(LYR):1.83
ROE:9.18%
ROA:8.37%
PB:4.88
PE(LYR):49.08

Loading ...

Baird Adjusts Price Target on Edwards Lifesciences to $87 From $85, Maintains Neutral Rating

MT Newswires Live
·
Apr 24

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW) and Sanofi (OtherSNYNF)

TIPRANKS
·
Apr 24

Edwards Lifesciences Shares up 2.2% Premarket After Q1 Revenue, Profit Beat

THOMSON REUTERS
·
Apr 24

U.S. RESEARCH ROUNDUP-Elevance Health, Huntington Bancshares, Monolithic Power Systems

Reuters
·
Apr 24

Edwards Lifesciences Corp : Canaccord Genuity Cuts Target Price to $85 From $87

THOMSON REUTERS
·
Apr 24

Edwards Lifesciences Corp : Truist Securities Raises Target Price to $90 From $89

THOMSON REUTERS
·
Apr 24

Edwards Lifesciences (EW) Gets a Buy from TD Cowen

TIPRANKS
·
Apr 24

Edwards Lifesciences beats quarterly estimates on robust demand for artificial heart valves

Reuters
·
Apr 24

Edwards Lifesciences Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Apr 24

Edwards Lifesciences Raises Full Year Outlook After 1Q Beat

Dow Jones
·
Apr 24

Edwards Lifesciences sees Q2 EPS 70c-76c, consensus 75c

TIPRANKS
·
Apr 24

Edwards Lifesciences Q1 sales rise 16.7%, beat estimates

Reuters
·
Apr 24

Edwards Lifesciences reports Q1 EPS 78c, consensus 73c

TIPRANKS
·
Apr 24

Edwards Lifesciences raises FY26 EPS view to $2.95-$3.05 from $2.90-$3.05

TIPRANKS
·
Apr 24

BRIEF-Edwards Lifesciences Q1 Adjusted EPS USD 0.78 Vs. IBES Estimate USD 0.73

Reuters
·
Apr 24

Edwards Lifesciences Q1 Adjusted EPS USD 0.78 VS. Ibes Estimate USD 0.73

THOMSON REUTERS
·
Apr 24

Edwards Lifesciences Corp FY2026 Shr View $2.93, REV View $6.68 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
Apr 24

Edwards Lifesciences Corp - Expects FY2026 Sales of $6.5-$6.9 Bln; Tavr Sales $4.7-$5.0 Bln

THOMSON REUTERS
·
Apr 24

Edwards Lifesciences Corp Q2 Shr View $0.75, REV View $1.68 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
Apr 24

Edwards Lifesciences Corp: Raising Midpoint of Its FY Adj EPS Guidance With a New Range of $2.95 to $3.05

THOMSON REUTERS
·
Apr 24